Related Tags >> Arena Pharmaceuticals obesity Vivus Clinical Trial Results

lorcaserin News

Most Popular lorcaserin Story

Three biotechs race for Holy Grail of drug development

October 19, 2009 — 7:11am ET | By John Carroll

One of the most closely watched competitions in biotechnology involves the final sprint toward marketing approval by Orexigen Therapeutics, Vivus and Arena Pharmaceuticals, each of which is at work Read more...

lorcaserin Press Releases

Arena Submits Response to FDA Complete Response Letter for Lorcaserin
FDA Issues Complete Response Letter for Lorcaserin New Drug Application
Arena Pharmaceuticals Announces Second Quarter 2010 Financial Results and Recent Developments
Eisai to Market Arena Pharmaceuticals' Lorcaserin for Obesity and Weight Management in U.S. Following FDA Approval

Latest Headlines

Arena Pharma raises $33M
January 11, 2012
Arena shares shine, briefly, as it presents its case for obesity drug
January 4, 2012
Can Arena's latest safety study help satisfy FDA's cancer worries?
August 2, 2011
Arena stands by plan to short-circuit rat study for lorcaserin
May 11, 2011
Arena ($ARNA) shares slide after it slashes staff, outlines FDA's lorcaserin demands
January 27, 2011
Arena maps out its one-year plan for lorcaserin
December 22, 2010
Arena ($ARNA) touts new obesity data as it campaigns for quick OK
November 9, 2010
Analysts take on obesity drugs turns grim after lorcaserin CRL
October 26, 2010
After FDA's ARNA decision, what's next for obesity drugs?
October 25, 2010
Timeline: A look back at Arena's lorcaserin
October 25, 2010
FDA throws up a tricky roadblock for Arena's lorcaserin
October 24, 2010
FDA responds to outraged Arena investors
October 22, 2010
Loyal Arena investors battling for diet drug approval
October 14, 2010
Lawsuits start to pile up in wake of Arena setback
September 23, 2010
Arena fails to convince FDA panel on obesity drug
September 16, 2010
Arena faces FDA panel today
September 16, 2010
Arena shares dive ahead of expert panel meeting
September 14, 2010
Did the odds just get worse for Arena's new weight drug?
August 9, 2010
Orexigen weight-loss drug shows positive results in study
July 30, 2010
Arena shares surge on new round of promising lorcaserin data
July 15, 2010

Paid Research Reports

More Research Reports >>